Here are five notes:
1. BMO Capital Markets currently has an $88 price target on Stryker’s stock, down from their prior price target of $105.
2. Three research analysts have given the stock a ‘sell’ rating, seven have issued a ‘hold’ rating and twelve have given it a ‘buy’ rating.
3. Stryker stock has a one-year low of $89.81 and a one-year high of $105.34.
4. The stock’s 50-day moving average is $95.65 and its 200 day moving average is $97.50.
5. Stryker has a market capitalization of $34.68 billion.
More articles on devices:
Did Loma Linda’s orthopedic device rep-less strategy work? 5 things to know
Could the medical device excise tax actually go away in the tax cuts package? 5 key notes
Exactech director sells 1.5k shares — 5 facts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
